about
Single-balloon enteroscopyThe clinical utility of single-balloon enteroscopy: a single-center experience of 172 proceduresOpen access endoscopy.Clinical applications of the argon plasma coagulator.A lexicon for endoscopic adverse events: report of an ASGE workshop.Identifying and reporting risk factors for adverse events in endoscopy. Part II: noncardiopulmonary events.Grading the complexity of endoscopic procedures: results of an ASGE working party.Diagnostic and therapeutic direct peroral cholangioscopy using an intraductal anchoring balloon.Jejunal cavernous lymphangioma.Prospective preoperative determination of mucinous pancreatic cystic neoplasms.Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.Therapeutic management options for patients with obscure gastrointestinal bleeding.Propofol: a gastroenterologist's perspective.Minimizing complications: sedation and monitoring.Endoscopic clips for closing esophageal perforations: case report and pooled analysis.Balloon dilation of colonic strictures.Sedation and anesthesia in GI endoscopy.Procedural sedation and obesity: waters left uncharted.Position statement: Nonanesthesiologist administration of propofol for GI endoscopy.Managing acute upper GI bleeding, preventing recurrences.Procedural sedation.Sedation in the bariatric patient.Basic requirements of gastroenterologists to treat upper gastrointestinal bleeding: competency and sedation issues.Antegrade is more effective than retrograde enteroscopy for evaluation and management of suspected small-bowel disease.Adding triamcinolone to endoscopic ultrasound-guided celiac plexus blockade does not reduce pain in patients with chronic pancreatitis.Development and validation of the patient and clinician sedation satisfaction index for colonoscopy and upper endoscopy.Bispectral index monitoring of conscious sedation with the combination of meperidine and midazolam during endoscopy.Computer-assisted propofol administration.Sedation by non-anesthesiologists: are opioids and benzodiazepines outdated?Combined endoscopic ultrasound and secretin endoscopic pancreatic function test in patients evaluated for chronic pancreatitis.Position statement: nonanesthesiologist administration of propofol for GI endoscopy.Approaches to the prevention and management of radiation colitis.A multicenter, prospective, randomized comparison of a novel signal transmission capsule endoscope to an existing capsule endoscope.Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.Surgical versus nonsurgical management of pancreatic pseudocysts.Delay in performing ERCP and adverse events increase the 30-day readmission risk in patients with acute cholangitis.Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.Quantitative assessment of psychomotor recovery after sedation and analgesia for outpatient EGD.Propofol may be safely administered by trained nonanesthesiologists. Pro: Propofol demystified: it is time to change the sedation paradigm.Electrolyte composition of endoscopically collected duodenal drainage fluid after synthetic porcine secretin stimulation in healthy subjects.
P50
Q28253622-294ADCC8-22DF-42DA-94BA-DD6CD6C39261Q28280346-07C0B821-254C-4313-966F-91745E1B0CC3Q30482413-1782E524-8D42-46C0-95BA-8D2AA7C8C03DQ31035750-86B4DA97-D788-4D52-B5AE-C0E65E73D33CQ34101032-C14FBF90-02B1-45A9-8B7B-378E7900F487Q34167058-76E07BA3-9B55-4D31-8C42-965CE6D7AEBAQ34168765-7EC184E9-715D-43FA-A301-071DDF68982AQ34388390-ABD9E668-BEB5-4B16-90E4-9D566446E6EAQ34982314-BDAED46F-2A2C-4DB6-AE0A-78E14D1BB74EQ34983769-158B00B2-5FBD-458E-987C-F1986E0E7F96Q35020936-E834C2B3-E173-4CA8-BE96-C033A08695D2Q35688579-63FDBE0D-DA63-42AD-873D-D4C7FE5E499EQ35761954-B7827433-2EC4-4DE0-A123-90473BC90C48Q36775748-F97D8907-1E56-4CCB-AE88-810EB323AF25Q36921733-381AC610-AD2D-4508-9226-07586BA2D803Q36952626-634468F1-A37E-4F45-BD3C-AEE44B926F66Q37227318-8B830B30-E131-4B04-8392-E81102897C0FQ37625167-D21879E7-B906-4919-888F-9B4486AAE7B3Q37643412-1FE42B49-FA0D-43B8-9EDC-6B63ED6A1655Q37685798-34D83076-9A4E-4094-B5F6-541F4BBDA91AQ37773769-2DE5C44B-C83F-4C4B-A3F2-66D5566696C9Q37875313-C4968499-8DC4-4CC4-840C-480D5491D6B8Q37938064-466E1DBA-7C51-412A-8869-9CCDCEB71393Q38011575-274AEB82-5882-4AA3-B597-2096DAC48A48Q39258825-0E411FFE-A416-4576-AF4F-E500EFEBC405Q40035423-BA568510-CD45-4587-BD11-FA47F9604D92Q40146167-53561012-FCC3-46DD-B829-2BAF7A1AEB3DQ43091418-9703E900-DFF0-45F2-9F0C-D0BD06E354EAQ43091425-878C269E-75A8-4EB5-BA2F-7506E5628F87Q43184245-CFC59E39-4776-4516-81BD-E5727674248AQ43229359-C67D0520-8503-46FC-BDFF-F525617D4A64Q43364496-10398C02-20FD-423D-8D02-0FBC1C44C3ACQ43687764-0F488F04-53E9-4122-BE58-22925E43BBBDQ44054010-7E5DD825-0F03-4FDA-8115-41496DE5CB34Q44082345-CB7FE8D3-88AE-4565-AF5F-F31577B3233DQ44191132-64A09A4C-C234-4DF6-8F65-15D6E38A78DAQ44208603-6AE80656-CE44-4FD4-B47E-70768FAA144EQ44226320-6DC5128D-766E-4EAB-8F3A-EE6B17AE7D7BQ44963238-700F56C2-6953-4A19-87A8-D715670DF3EFQ45032808-65D4E272-8236-4F6D-B8EA-E98BA9652B99
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Vargo
@ast
John Vargo
@en
John Vargo
@es
John Vargo
@nl
John Vargo
@sl
type
label
John Vargo
@ast
John Vargo
@en
John Vargo
@es
John Vargo
@nl
John Vargo
@sl
prefLabel
John Vargo
@ast
John Vargo
@en
John Vargo
@es
John Vargo
@nl
John Vargo
@sl
P106
P1153
7005214048
P21
P31
P496
0000-0001-7638-5283